Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

April 20, 2023

Study Completion Date

March 15, 2028

Conditions
Tricuspid Valve Insufficiency
Interventions
DEVICE

Edwards PASCAL Transcatheter Valve Repair System

The Edwards PASCAL Valve Repair System is indicated for the percutaneous reconstruction of an insufficient tricuspid valve.

DEVICE

Edwards PASCAL Precision Transcatheter Valve Repair System

The Edwards PASCAL Precision Valve Repair System is indicated for the percutaneous reconstruction of an insufficient tricuspid valve.

Trial Locations (15)

3010

Inselspital, Bern

20246

UKE Hamburg, Hamburg

22087

Kath. Marienkrankenhaus Hamburg gGmbH, Hamburg

32545

Herz- und Diabeteszentrum NRW - Bad Oeynhausen, Bad Oeynhausen

45147

Westdeutsches Herz- und Gefäßzentrum Klinik für Kardiologie und Angiologie, Essen

53127

Herzzentrum der Universitätsklinik Bonn, Bonn

72076

Universitätsklinikum Tübingen Innere Medizin III - Kardiologie und Angiologie, Tübingen

81377

Medizinische Klinik I- Campus Grosshadern, München

89070

Universitätsklinikum Ulm Innere Medizin II, Ulm

99437

Zentralklinik Bad Berka GmbH, Bad Berka

D-50937

Herzzentrum Universitätsklinikum Köln, Cologne

04289

Heart Centre of the University Leipzig, Leipzig

Unknown

University Heart Center Lübeck, Lübeck

"Ospedale del Cuore G. Pasquinucci", Massa

151 23

Hygeia Hospital, Athens

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY